A major lawsuit filed on Thursday says pharmaceutical giant Johnson & Johnson has misled customers for decades about the ...

A class action filed today says Kiwis have been deceived for about two decades through the use of phenylephrine in cold and ...

Law firm JGA Saddler rolls out big class action against Johnson & Johnson, on basis that Sudafed and Codral’s main ingredient ...

Johnson & Johnson is looking to sell its Cerenovus stroke therapy business, according three unnamed people "with knowledge of ...

Johnson & Johnson (NYSE:JNJ) is a healthcare company engaged in the research, development, manufacturing, and marketing of a ...

We recently published a list of the 10 Best Medical Device Stocks To Buy According to Hedge Funds. In this article, we are ...

Johnson & Johnson is considering selling its stroke care unit, Cerenovus, in a potential $1 billion deal as part of its ...

Johnson & Johnson (NYSE:JNJ), the New Jersey-based healthcare company, is planning to sell its stroke care business, ...

Pharmaceutical giant Johnson & Johnson (JNJ) is planning to sell its stroke care business called “Cerenovus” for $1 billion ...

Johnson & Johnson (NYSE:JNJ) has put its stroke care business up for sale, aiming for a valuation of more than $1B, the Financial Times reported on Tuesday, citing people familiar with the matter.